The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: A hypothesis to explain its specific vulnerability

Journal of Neurotrauma

Volumn 17, Issue 3, 2000, Pages 251-260

  Nishino, Hitoo ^a   Hida, Hideki ^a   Kumazaki, Michiko ^a   Shimano, Yasunobu ^a   Nakajima, Keiya ^a   Shimizu, Hideo ^a   Ooiwa, Takanori ^a   Baba, Hiroko ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Astrocytes; Blood brain barrier; Endothelial cells; Energy compromise; Lateral striatal artery; Mitochondrial toxin; Neurodegeneration; Striatum

Indexed keywords

NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN REGION; CELL DEATH; CORPUS STRIATUM; ENDOTHELIUM CELL; ENERGY METABOLISM; MALE; MITOCHONDRION; NERVE DEGENERATION; NEUROIMMUNOLOGY; NONHUMAN; PATHOGENESIS; RAT;

EID: 0034022333     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2000.17.251     Document Type: Article

References (40)

1. ALEXI, T., HUGHES, P.E., FAULL, R.L.M., et al. (1998). 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. Neuroreport 9, R57-R64.
2. AOKI, M., OGASAWARA, M., MATSUBARA, Y., et al. (1993). Mild ALS in Japan associated with novel SOD mutation. Nat. Genet. 5, 323-324.
3. BARRES, B.A. (1991). New roles for glia. J. Neurosci. 11, 3685-3694.
4. BEAL, M.F. (1992). Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illness? Ann. Neurol. 31, 119-130.
5. BEAL, M.F., BROUILLET, E., JENKINS, B.G., et al. (1993). Neurochemical and histological characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13, 4181-4192.
6. BEN-SHACHAR, D., ZUK, R., and GLINKA, Y. (1995). Dopamine neurotoxicity: inhibition of mitochondrial respiration. J. Neurochem. 64, 718-723.
7. BORLONGAN, C.V., NISHINO, H., and SANBERG, P.R. (1997). Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation. Neurosci. Res. 28, 185-189.
8. BRENNAN, W.A., BIRD, E.D., and APRILL, J.R. (1985). Regional mitochondrial respiratory activity in Huntington's disease brain. J. Neurochem. 44, 1948-1950.
9. BRIGHTMAN, M.W., and TAO-CHENG, J.H. (1993). Tight junctions of brain endothelium and epithelium, in: The Blood-Brain Barrier. W.M. Pardridge (ed), Raven Press: New York, pps. 107-125.
10. BROUILLET, M., HANTRAYE, P., FERRANTE, R.J., et al. (1995). Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl. Acad. Sci. U.S.A. 92, 7105-7109.
11. BROWNE, S.E., BOWLING, A.C., MACGARVEY, U., et al. (1997). Oxidative damage and metabolic dysfunction in Hungtington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646-653.
12. CANCILLA, P.A., BREADY, J., and BERLINER, J. (1993). Brain endothelial-astrocyte interactions, in: The Blood-Brain Barrier. W.M. Pardride (ed), Raven Press: New York, pps. 25-46.
13. CHOI, D. (1988). Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
14. DENG, H.X., HENTATI, A., TAINER, J.A., et al. (1993). Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261, 1047-1051.
15. DUYAO, M., AMBROSE, C., MYERS, R., et al. (1993). Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat. Genet. 4, 387-392.
16. GOATE, A., CHARTIER-HARLIN, M.C., MULLAN, M., et al. (1991). Segregation of missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
17. HAMILTON, B.F., and GOULD, D.H. (1987b). Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol. 74, 67-74.
18. HAMILTON, F., and GOULD, D.H. (1987a). Correlation of morphologic brain lesions with physiologic alterations and blood-brain barrier impairment in 3-nitropropionic acid toxicity in rats. Acta Neuropathol. 74, 67-74.
19. HARLAN, J.M., WIN, R.K., VEDDER, N.B., et al. (1992). In vivo models of leukocyte adherence to endothelium, in: Adhesion, Its Role in Inflammatory Disease. J.M. Harlen and D.Y. Liu (eds), W.H. Freeman: New York, pps. 117-150.
20. HE, F., SHOULIN, Z., QIAN, F., et al. (1995). Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid). Neurology 45, 2178-2183.
21. HE, F., ZHANG, S., ZHANG, C., et al. (1990). Mycotoxin-induced encephalopathy and dystonia in children, in: Basic Science in Toxicology. G.N. Volans, J. Sims, F.M. Sullivan, and P. Turner (eds), Taylor and Francis: London, pps. 596-604.
22. HENN, V., SLUPSKY, J.R., GRAFE, M., et al. (1998). CD 40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391, 591-594.
23. HIER, D.B., DAVIS, K.R., RICHARDSON, E.P., JR., et al. (1977). Hypertensive putaminal hemorrhage. Ann. Neurol. 1, 152-159.
24. KITADA, T., ASAKAWA, S., HATTORI, N., et al. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608.
25. LIN, C.L.G., BRISTOL, L.A., JIN, L., et al. (1998). Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20, 589-602.
26. LUDOLPH, A.C., HE, F., SPENCER, P.S., et al. (1991). 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18, 492-498.
27. MASAWA, N., YOSHIDA, Y., JOSHITA, T., et al. (1993). Pathogenesis of medial necrosis as the cause of hypertensive intracerebral hemorrhage. Nippon Rinsho 664, 16-23.
28. NISHINO, H., HASHITANI, T., KUMAZAKI, M., et al. (1990). Long-term survival of grafted cells, dopamine synthesis, release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway. Brain Res. 534, 83-93.
29. NISHINO, H., KUMAZAKI, M., FUKUDA, A., et al. (1997). Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity. Neurosci. Res. 27, 343-355.
30. NISHINO, H., NAKAJIMA, K., KUMAZAKI, M., et al. (1998). Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid. Neurosci. Res. 30, 303-312.
31. NISHINO, H., SHIMANO, Y., KUMAZAKI, M., et al. (1995). Chronically administered 3-nitropropionic acid induces striatal attributed to dysfunction of the blood-brain barrier. Neurosci. Lett. 186, 161-164.
32. OLNEY, J.W. (1978). Neurotoxicity of excitatory amino acids, in: Kainic Acid as a Tool in Neurobiology. E.G. McGeer, J.W. Olney, and P.L. McGeer (eds), Raven Press: New York, pps. 95-121.
33. POLYMEROPOULOS, M.H., LAVEDAN, C., LEROY, E., et al. (1997). Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
34. ROSEN, D.R., SIDDIQUE, T., PATTERSON, D., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amytrophic lateral sclerosis. Nature 362, 59-62.
35. ROSNER, S.S., RHOTON, A.L., Jr., and Ono, M., et al. (1984). Microsurgical anatomy of the anterior perforating arteries. J. Neurosurg. 61, 468-485.
36. SCHULZ, J.B., MATTHEWS, R.T., JENKINS, B.C., et al. (1995). Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15, 8419-8429.
37. SIMPSON, J.R., and ISACSON, O. (1993). Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum. Exp. Neurol. 121, 57-64.
38. THE HUNTINGTON'S DISEASE COLLABORATIVE RESEARCH GROUP (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome. Cell 72, 971-983.
39. UNGERSTEDT, U., and ARBUTHNOTT, G.W. (1970). Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions on the nigrostriatal dopamine system. Brain Res. 24, 485-493.
40. WARE, J.A., and HEISTAD, D.D. (1993). Platelet-endothelium interactions. N. Engl. J. Med. 328, 628-635.